SPONSOR

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Total Trials

Recruiting

Phases

Phase 2, Phase 3, Phase 1

Conditions studied: Multi-modality Echocardiography Primary Electrical Disease Thyroid Nodule Chronic Tinnitus Exploring the Correlation of HRD Score Pairs with the Prognosis of Chinese Ovarian Cancer Patients and the Outcome of Maintenance Therapy with PARPi Neuroblastoma Carpal Tunnel Syndrome Head and Neck Cancers - Hypopharyngeal Rheumatoid Arthritis Breast Cancer

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University is a clinical research sponsor with 17 registered studies on ClinicalTrials.gov, of which 17 are actively recruiting participants. Research covers conditions including Multi-modality Echocardiography, Primary Electrical Disease, Thyroid Nodule, Chronic Tinnitus.

The trial portfolio spans Phase 2, Phase 3, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

How many clinical trials has Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University sponsored?

ClinicalMetric currently tracks 17 clinical trials sponsored by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, of which 17 are actively recruiting participants. These trials cover conditions including Multi-modality Echocardiography, Primary Electrical Disease, Thyroid Nodule. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University research focus on?

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University clinical trials span Multi-modality Echocardiography, Primary Electrical Disease, Thyroid Nodule, Chronic Tinnitus, Exploring the Correlation of HRD Score Pairs with the Prognosis of Chinese Ovarian Cancer Patients and the Outcome of Maintenance Therapy with PARPi, and additional conditions. The research pipeline includes Phase 2, Phase 3, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University clinical trial?

To participate in a Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University trials with current recruitment status updated daily.

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Frequently Asked Questions — Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Clinical Trials by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Multi-modality Echocardiography for Cardiac Assessment in Primary Electrical Disease

Multimodal Assessment of Malignancy in Atypia of Undetermined Significance in Thyroid Nodules Using Ultrasound and Cytology Whole-Slide Images

Efficacy Analysis of Personalized-Target Transcranial Magnetic Stimulation (TMS) in the Treatment of Chronic Tinnitus: A Single-Center, Single-Blind Randomized Clinical Trial

Exploratory Study on the Correlation Between HRD Score and PARPi Efficacy Based on Chinese Ovarian Cancer Patients

Arsenic Trioxide With MAPK Inhibitors and Chemotherapy for Stage 4/M Neuroblastoma

Ultrasound-Guided Curved Needle Thread Carpal Tunnel Release: Efficacy and Safety of a Single-Center, Single-Arm Clinical Trial

Submental Flap for the Reconstruction of Hypopharyngectomy

Methotrexate Combined With Tofacitinib in Rheumatoid Arthritis

Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast Cancer

Herombopag Treated T-DM1 Induced Platelet Reduction

AI Recognition of Important Structures in Otolaryngological Surgery

Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients

Study Of Capecitabine Combined With Camrelizumab For Non-pCR TNBC With TLS After Neoadjuvant Chemoterapy

Disitamab Vedotin + Pyrotinib Versus THP in the First-line Treatment for HER2+ Advanced Breast Cancer Clinical Trial

Efficacy and Safety of Extended-Dose Interval Immunotherapy Versus Standard-Dose Interval Immunotherapy for Advanced Triple-Negative Breast Cancer

Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms

A Prospective Cohort Study On Change of Cognitive Function In Aged-related Hearing Loss With Hearing Aids